drugset / Trial / NCT01081821

Single and Multiple Dose Study to Explore the Safety and Pharmacokinetics of JNJ-39758979 In Healthy Male Volunteers of Either Caucasian or Japanese Descent

NCT01081821

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to investigate the safety, tolerability and pharmacokinetics (how the drug is absorbed in the body, how it is distributed within the body and it is removed from the body over time) of single doses of JNJ-39758979 in healthy Japanese volunteers and multiple doses of JNJ-39758979 in healthy Japanese and Caucasian volunteers.

Timeline

Start
2010-02
Primary completion
2010-12
Completion
2010-12

Drugs

EvaluationDrugModalityDoseRoute
Subject JNJ-39758979 Small molecule 50 mg Oral
Subject JNJ-39758979 Small molecule 100 mg Oral
Subject JNJ-39758979 Small molecule 300 mg Oral
Subject JNJ-39758979 Small molecule 600 mg Oral

Indications

No indication recorded.